As the U.S.-Iran standoff continues, Goldman Sachs unveiled its price target for Brent crude oil on Aug. 4. The bank said it expects Brent crude to trade in the range of $80-$90 a barrel until there is either confirmation of a new nuclear deal or a significant escalation of the conflict, as ...
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
I covered Wells Fargo's AMD upgrade at the start of July, making a specific case that the server CPU story was being underappreciated relative to the GPU narrative. On July 5, 57-year-old Goldman Sachs also made the same argument louder and with a bigger number. Goldman Sachs analyst James ...
SpaceX (SPCX) didn’t enter the market quietly. Its blockbuster debut has instantly made it one of the most-watched companies on Wall Street, with investors chasing a rare public-market play on rockets, satellites, Starlink, and Elon Musk’s next frontier. The first major analyst calls are landing ...
In February and March 2026, Snowflake was the stock Wall Street couldn't quite figure out. The stock was down 50% from the early January high to early April 2026, according to TradingView data. Snowflake was caught between a decelerating core business and an AI narrative that kept getting pushed ...
When a stock jumps 13% in the session after earnings day, and the analyst covering it still cuts the price target, something interesting is happening, and you may want to dig beneath the surface. That is exactly the situation unfolding at Figma (FIG) right now. The design software company delivered ...
Biogen (NASDAQ: BIIB) has had a rocky few years. Its multiple sclerosis franchise has been bleeding market share to generics and biosimilars, revenue has trended down, and the stock spent much of 2025 trading near multi-year lows. So when Goldman Sachs steps up with a price target hike to $250, ...